Pub Date : 2025-09-01Epub Date: 2025-05-19DOI: 10.1177/10892532251343169
Katharina Seuthe, Benjamin Schuldes, Parwis Rahmanian, Henrik Ten Freyhaus, Bernd W Böttiger, Wolfgang A Wetsch, Michael Vandenheuvel, Eckhard Mauermann, Jakob Labus
Background: The novel method of non-invasive right ventricular (RV) myocardial work (MW) analysis provides a load-independent assessment of RV function by combining myocardial strain with loading conditions. However, its use has not been well described in the perioperative setting to date. We aimed to evaluate the feasibility of assessing RV MW, and to describe the perioperative course of this new technique. Methods: In this retrospective study, patients scheduled for LVAD surgery were evaluated for feasibility of RV MW analysis. Preoperative (T1) and postoperative (T2) transthoracic echocardiography (TTE) included the assessment of conventional echocardiographic measurements, myocardial strain, global work index (GWI), global constructive work (GCW), global wasted work (GWW), and global work efficiency (GWE) for the evaluation of RV function. Results: Ten patients had complete TTE data available for RV MW analysis, which indicated significant reduction of effective and ineffective RV MW (GWI, 212 mmHg% (IQR 128; 266) v 96 mmHg% (IQR 63; 150), P = 0.02; GCW, 331 mmHg% (IQR 263; 476) v 198 mmHg% (IQR 136; 274), P < 0.01; GWW, 171 mmHg% (IQR 102; 243) v 98 mmHg% (IQR 48; 153), P = 0.04), while GWE remained stable (69% (IQR 37; 78) v 64% (IQR 61; 78), P = 0.26) after LVAD implantation. Conventional parameters were not able to detect these changes. Moreover, there were different trends of RV MW indices in patients with and without postimplant RV failure. Conclusion: This study demonstrates that non-invasive RV MW assessment is feasible in the perioperative setting of LVAD implantation and provides valuable insights into RV function that are not captured by conventional echocardiographic methods. Further research is warranted to validate these findings.
背景:无创右心室(RV)心肌功(MW)分析的新方法通过结合心肌应变和负荷条件,提供了一种独立于负荷的右心室功能评估方法。然而,到目前为止,它在围手术期的应用还没有很好的描述。我们的目的是评估评估RV MW的可行性,并描述这项新技术的围手术期过程。方法:在这项回顾性研究中,对计划进行LVAD手术的患者进行RV MW分析的可行性评估。术前(T1)和术后(T2)经胸超声心动图(TTE)包括评估常规超声心动图测量、心肌应变、整体功指数(GWI)、整体建设性功(GCW)、整体浪费功(GWW)和整体工作效率(GWE),以评估右心室功能。结果:10例患者有完整的TTE数据可用于RV MW分析,表明有效和无效RV MW (GWI, 212 mmHg% (IQR 128;266) v 96 mmHg% (IQR 63;150), p = 0.02;GCW, 331mmhg % (IQR 263;476) v 198 mmHg% (IQR 136;274), p < 0.01;GWW, 171 mmHg% (IQR 102;243) v 98 mmHg% (IQR 48;153), P = 0.04),而GWE保持稳定(69% (IQR 37;78) v 64% (IQR 61;78), P = 0.26)。常规参数无法检测到这些变化。此外,移植后右心室功能衰竭患者和非移植后右心室功能衰竭患者右心室MW指数的变化趋势也不同。结论:本研究表明,无创左室MW评估在LVAD植入围术期是可行的,并为传统超声心动图方法无法捕获的左室功能提供了有价值的见解。需要进一步的研究来证实这些发现。
{"title":"Evaluation of Perioperative Non-Invasive Right Ventricular Myocardial Work in Left Ventricular Assist Device Implantation.","authors":"Katharina Seuthe, Benjamin Schuldes, Parwis Rahmanian, Henrik Ten Freyhaus, Bernd W Böttiger, Wolfgang A Wetsch, Michael Vandenheuvel, Eckhard Mauermann, Jakob Labus","doi":"10.1177/10892532251343169","DOIUrl":"10.1177/10892532251343169","url":null,"abstract":"<p><p><b>Background:</b> The novel method of non-invasive right ventricular (RV) myocardial work (MW) analysis provides a load-independent assessment of RV function by combining myocardial strain with loading conditions. However, its use has not been well described in the perioperative setting to date. We aimed to evaluate the feasibility of assessing RV MW, and to describe the perioperative course of this new technique. <b>Methods:</b> In this retrospective study, patients scheduled for LVAD surgery were evaluated for feasibility of RV MW analysis. Preoperative (T1) and postoperative (T2) transthoracic echocardiography (TTE) included the assessment of conventional echocardiographic measurements, myocardial strain, global work index (GWI), global constructive work (GCW), global wasted work (GWW), and global work efficiency (GWE) for the evaluation of RV function. <b>Results:</b> Ten patients had complete TTE data available for RV MW analysis, which indicated significant reduction of effective and ineffective RV MW (GWI, 212 mmHg% (IQR 128; 266) v 96 mmHg% (IQR 63; 150), <i>P</i> = 0.02; GCW, 331 mmHg% (IQR 263; 476) v 198 mmHg% (IQR 136; 274), <i>P</i> < 0.01; GWW, 171 mmHg% (IQR 102; 243) v 98 mmHg% (IQR 48; 153), <i>P</i> = 0.04), while GWE remained stable (69% (IQR 37; 78) v 64% (IQR 61; 78), <i>P</i> = 0.26) after LVAD implantation. Conventional parameters were not able to detect these changes. Moreover, there were different trends of RV MW indices in patients with and without postimplant RV failure. <b>Conclusion:</b> This study demonstrates that non-invasive RV MW assessment is feasible in the perioperative setting of LVAD implantation and provides valuable insights into RV function that are not captured by conventional echocardiographic methods. Further research is warranted to validate these findings.</p>","PeriodicalId":46500,"journal":{"name":"Seminars in Cardiothoracic and Vascular Anesthesia","volume":" ","pages":"182-191"},"PeriodicalIF":1.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144095387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01Epub Date: 2025-02-14DOI: 10.1177/10892532251321062
Mirjana Gander, Joanna Kochanska-Bieri, Firmin Kamber, Denis Berdajs, David Santer, Daniel Bolliger, Eckhard Mauermann
Introduction: Postoperative atrial fibrillation (POAF) after cardiac surgery is associated with higher morbidity and mortality. This paper presents several studies that conclude the presence of an aberrant p-terminal force vector in lead V1 (PTFV1) has been identified as a significant predictor of atrial fibrillation in the non-surgical population. It is uncertain whether or not there is an association of PTFV1 and new-onset POAF in patients after cardiac surgery. Methods: In this secondary analysis, adult patients undergoing on-pump cardiac surgery for aortocoronary bypasses, valve surgery, combined bypass, and valve surgery were analyzed from 12/2018 to 08/2020. Patients who had a previous occurrence of atrial fibrillation or atrial flutter, patients with pacemakers and/or Implantable Cardioverter-Defibrillators (ICDs), and those who did not have an electrocardiogram (ECG) performed within the 3 months before surgery were excluded. In addition, ECGs that were considered to be of low quality were also removed. Preoperative 12-lead ECGs were examined and the PTFV1 was measured. Secondarily, we examined the P-wave length in lead II, the area under the P-wave in lead II, PR interval, and QRS duration in lead V1 and II. The occurrence of POAF was extracted from the hospital record. Results: Out of a total of 252 patients, 62 patients (24.6%) developed new onset POAF during their hospital stay. POAF occurred primarily in older patients, with poor renal function, and exhibited larger left atria. Analysis of ORs (odds ratios) revealed that age, creatinine clearance, valve surgery, and left atrial volume index (LAVI) were associated with POAF. In the context of the multivariable analysis, it was demonstrated that only age presented a significant correlation with postoperative atrial fibrillation (POAF). There was no observed relationship between any of the parameters based on ECG and the occurrence of POAF. Conclusion: No association was found between PTFV1 or other ECG-based measurements and new onset POAF in cardiac surgery patients. Age was the only independent predictor of POAF.
{"title":"The Association of New Onset Postoperative Atrial Fibrillation and Abnormal P-Terminal Force in Lead V1 After On-Pump Cardiac Surgery.","authors":"Mirjana Gander, Joanna Kochanska-Bieri, Firmin Kamber, Denis Berdajs, David Santer, Daniel Bolliger, Eckhard Mauermann","doi":"10.1177/10892532251321062","DOIUrl":"10.1177/10892532251321062","url":null,"abstract":"<p><p><b>Introduction:</b> Postoperative atrial fibrillation (POAF) after cardiac surgery is associated with higher morbidity and mortality. This paper presents several studies that conclude the presence of an aberrant p-terminal force vector in lead V1 (PTFV1) has been identified as a significant predictor of atrial fibrillation in the non-surgical population. It is uncertain whether or not there is an association of PTFV1 and new-onset POAF in patients after cardiac surgery. <b>Methods:</b> In this secondary analysis, adult patients undergoing on-pump cardiac surgery for aortocoronary bypasses, valve surgery, combined bypass, and valve surgery were analyzed from 12/2018 to 08/2020. Patients who had a previous occurrence of atrial fibrillation or atrial flutter, patients with pacemakers and/or Implantable Cardioverter-Defibrillators (ICDs), and those who did not have an electrocardiogram (ECG) performed within the 3 months before surgery were excluded. In addition, ECGs that were considered to be of low quality were also removed. Preoperative 12-lead ECGs were examined and the PTFV1 was measured. Secondarily, we examined the P-wave length in lead II, the area under the P-wave in lead II, PR interval, and QRS duration in lead V1 and II. The occurrence of POAF was extracted from the hospital record. <b>Results:</b> Out of a total of 252 patients, 62 patients (24.6%) developed new onset POAF during their hospital stay. POAF occurred primarily in older patients, with poor renal function, and exhibited larger left atria. Analysis of ORs (odds ratios) revealed that age, creatinine clearance, valve surgery, and left atrial volume index (LAVI) were associated with POAF. In the context of the multivariable analysis, it was demonstrated that only age presented a significant correlation with postoperative atrial fibrillation (POAF). There was no observed relationship between any of the parameters based on ECG and the occurrence of POAF. <b>Conclusion:</b> No association was found between PTFV1 or other ECG-based measurements and new onset POAF in cardiac surgery patients. Age was the only independent predictor of POAF.</p>","PeriodicalId":46500,"journal":{"name":"Seminars in Cardiothoracic and Vascular Anesthesia","volume":" ","pages":"168-181"},"PeriodicalIF":1.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12340142/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143417073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01Epub Date: 2025-03-13DOI: 10.1177/10892532251325653
Manish Pandey
Internationally, extracorporeal membrane oxygenation (ECMO) is now a core and standard organ support tool to provide tertiary critical care and cardiac services within a network of hospitals and a key tool for running an effective and efficient cardio-respiratory pathways. The letter aims to put the spotlight on some of the missing clinical evidence on respiratory ECMO and including them will help to arrive at a better-informed national ECMO policy decision.
{"title":"Response on Rapid Review to Inform Policy Guidance on Welsh Respiratory ECMO Provision.","authors":"Manish Pandey","doi":"10.1177/10892532251325653","DOIUrl":"10.1177/10892532251325653","url":null,"abstract":"<p><p>Internationally, extracorporeal membrane oxygenation (ECMO) is now a core and standard organ support tool to provide tertiary critical care and cardiac services within a network of hospitals and a key tool for running an effective and efficient cardio-respiratory pathways. The letter aims to put the spotlight on some of the missing clinical evidence on respiratory ECMO and including them will help to arrive at a better-informed national ECMO policy decision.</p>","PeriodicalId":46500,"journal":{"name":"Seminars in Cardiothoracic and Vascular Anesthesia","volume":" ","pages":"203-208"},"PeriodicalIF":1.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143617296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01Epub Date: 2025-02-10DOI: 10.1177/10892532251316682
Cornelia K Niezen, Marco Modestini, Dario Massari, Arend F Bos, Thomas W L Scheeren, Michel M R F Struys, Jaap Jan Vos
IntroductionPostoperative acute kidney injury (AKI) is a common postoperative complication in cardiac surgery, with varying reported incidences and prognostic factors. Renal hypoperfusion is believed to be a key factor contributing to postoperative AKI. Near-infrared spectroscopy (NIRS) monitoring, which assesses regional tissue saturation (RSO2), has been suggested as a tool to predict postoperative AKI. The aim of this systematic review was to examine the prognostic value of perioperative NIRS monitoring in predicting postoperative AKI in pediatric patients.Methods and ResultsAfter a systematic search in PubMed, EMBASE, and Cochrane library, twenty studies (1517 patients) were included. The inter-rater agreement on study quality was strong, yet a high risk of bias was identified.ConclusionThe heterogeneity of the results-in part attributable to several potential confounding factors regarding study population, monitoring technique and the definition of AKI-together with the lack of a clear and consistent association between RSO2 values and AKI, currently preclude recommending NIRS monitoring as a reliable and valid clinical tool to "predict" AKI in the individual patient.
{"title":"Prognostic Value of Perioperative Near-Infrared Spectroscopy Monitoring for Postoperative Acute Kidney Injury in Pediatric Cardiac Surgery: A Systematic Review.","authors":"Cornelia K Niezen, Marco Modestini, Dario Massari, Arend F Bos, Thomas W L Scheeren, Michel M R F Struys, Jaap Jan Vos","doi":"10.1177/10892532251316682","DOIUrl":"10.1177/10892532251316682","url":null,"abstract":"<p><p>IntroductionPostoperative acute kidney injury (AKI) is a common postoperative complication in cardiac surgery, with varying reported incidences and prognostic factors. Renal hypoperfusion is believed to be a key factor contributing to postoperative AKI. Near-infrared spectroscopy (NIRS) monitoring, which assesses regional tissue saturation (RSO<sub>2</sub>), has been suggested as a tool to predict postoperative AKI. The aim of this systematic review was to examine the prognostic value of perioperative NIRS monitoring in predicting postoperative AKI in pediatric patients.Methods and ResultsAfter a systematic search in PubMed, EMBASE, and Cochrane library, twenty studies (1517 patients) were included. The inter-rater agreement on study quality was strong, yet a high risk of bias was identified.ConclusionThe heterogeneity of the results-in part attributable to several potential confounding factors regarding study population, monitoring technique and the definition of AKI-together with the lack of a clear and consistent association between RSO<sub>2</sub> values and AKI, currently preclude recommending NIRS monitoring as a reliable and valid clinical tool to \"predict\" AKI in the individual patient.</p>","PeriodicalId":46500,"journal":{"name":"Seminars in Cardiothoracic and Vascular Anesthesia","volume":" ","pages":"209-218"},"PeriodicalIF":1.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12340143/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143392306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01Epub Date: 2025-05-26DOI: 10.1177/10892532251348054
Jeffrey Park, Kathleen A Smith, Anthony G Charles, Alan M Smeltz
Flash pulmonary edema can affect up to 10% of women with preeclampsia. Although there is growing literature describing the use of extracorporeal membrane oxygenation (ECMO) in pregnant patients, there is very little research describing its use in the setting of preeclampsia. In this case report, an encouraging story of a woman with this complication who was successfully managed is described. In addition, the impact of normal physiologic changes of pregnancy on ECMO management is discussed.
{"title":"Flash Pulmonary Edema and Respiratory Failure in a Preeclamptic Patient Requiring Intrapartum Extracorporeal Membrane Oxygenation.","authors":"Jeffrey Park, Kathleen A Smith, Anthony G Charles, Alan M Smeltz","doi":"10.1177/10892532251348054","DOIUrl":"10.1177/10892532251348054","url":null,"abstract":"<p><p>Flash pulmonary edema can affect up to 10% of women with preeclampsia. Although there is growing literature describing the use of extracorporeal membrane oxygenation (ECMO) in pregnant patients, there is very little research describing its use in the setting of preeclampsia. In this case report, an encouraging story of a woman with this complication who was successfully managed is described. In addition, the impact of normal physiologic changes of pregnancy on ECMO management is discussed.</p>","PeriodicalId":46500,"journal":{"name":"Seminars in Cardiothoracic and Vascular Anesthesia","volume":" ","pages":"225-229"},"PeriodicalIF":1.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144151831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01Epub Date: 2024-12-22DOI: 10.1177/10892532241309787
Michal Pruski, Michael Beddard, Susan O'Connell, Andrew Champion, Rhys Morris, Richard Pugh, Iolo Doull
BackgroundWhile several studies have summarised the clinical effectiveness evidence for extracorporeal membrane oxygenation (ECMO), there are no evidence syntheses of the impact of centres' ECMO patient volume on patient outcomes or the impact of bedside ECMO care being delivered by either a perfusionist or a nurse. There is also limited information on the cost-effectiveness of ECMO.PurposeThis review was carried out to evaluate the clinical effectiveness and cost of different service delivery models of pulmonary ECMO to inform NHS Wales commissioning policy.Research DesignThe study utilised rapid review methodology, consisting of a systematic literature search and the inclusion of the highest quality of evidence available.Data CollectionOut of 1997 records identified via literature searches, 12 studies fell within the scope. The 2 meta-analyses comparing ECMO with lung-protective ventilation favoured ECMO.ResultsFive studies looking at the clinical impact of centre patient volume had large heterogeneity. Three studies estimated that with sufficient patient volume, nurse-delivered ECMO was cost-saving, with thresholds varying between 92 and 155 patient days per year. Three studies looked at the cost impact of ECMO delivery, with ECMO being cost incurring, but potentially cost-effective, with costs per patient being lower at higher volume centres.ConclusionsThe available evidence supports the use of ECMO in adult respiratory failure patients, despite it being cost-incurring. ECMO can be nurse-delivered without a significant negative impact on patient care. Yet decision-makers need to consider their local circumstances when making commissioning decisions.
{"title":"ECMO for Adult Respiratory Failure: A Rapid Review of Clinical and Service Delivery Evidence to Guide Policy in Wales.","authors":"Michal Pruski, Michael Beddard, Susan O'Connell, Andrew Champion, Rhys Morris, Richard Pugh, Iolo Doull","doi":"10.1177/10892532241309787","DOIUrl":"10.1177/10892532241309787","url":null,"abstract":"<p><p>BackgroundWhile several studies have summarised the clinical effectiveness evidence for extracorporeal membrane oxygenation (ECMO), there are no evidence syntheses of the impact of centres' ECMO patient volume on patient outcomes or the impact of bedside ECMO care being delivered by either a perfusionist or a nurse. There is also limited information on the cost-effectiveness of ECMO.PurposeThis review was carried out to evaluate the clinical effectiveness and cost of different service delivery models of pulmonary ECMO to inform NHS Wales commissioning policy.Research DesignThe study utilised rapid review methodology, consisting of a systematic literature search and the inclusion of the highest quality of evidence available.Data CollectionOut of 1997 records identified via literature searches, 12 studies fell within the scope. The 2 meta-analyses comparing ECMO with lung-protective ventilation favoured ECMO.ResultsFive studies looking at the clinical impact of centre patient volume had large heterogeneity. Three studies estimated that with sufficient patient volume, nurse-delivered ECMO was cost-saving, with thresholds varying between 92 and 155 patient days per year. Three studies looked at the cost impact of ECMO delivery, with ECMO being cost incurring, but potentially cost-effective, with costs per patient being lower at higher volume centres.ConclusionsThe available evidence supports the use of ECMO in adult respiratory failure patients, despite it being cost-incurring. ECMO can be nurse-delivered without a significant negative impact on patient care. Yet decision-makers need to consider their local circumstances when making commissioning decisions.</p>","PeriodicalId":46500,"journal":{"name":"Seminars in Cardiothoracic and Vascular Anesthesia","volume":" ","pages":"192-202"},"PeriodicalIF":1.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12340146/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142878291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01Epub Date: 2025-08-18DOI: 10.1177/10892532251366444
Kevin A Maar, Andrea Szekely, Benjamin Abrams, Miklos D Kertai
{"title":"Innovations in Risk Assessment, Monitoring, and Management in Cardiothoracic and Vascular Anesthesia.","authors":"Kevin A Maar, Andrea Szekely, Benjamin Abrams, Miklos D Kertai","doi":"10.1177/10892532251366444","DOIUrl":"10.1177/10892532251366444","url":null,"abstract":"","PeriodicalId":46500,"journal":{"name":"Seminars in Cardiothoracic and Vascular Anesthesia","volume":"29 3","pages":"165-167"},"PeriodicalIF":1.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144875878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Congenital heart block (CHB) is a rare congenital cardiac disease where disruption of the atrioventricular (AV) node results in cardiac conduction abnormalities. The majority of CHB cases are associated with neonatal lupus antibodies that are associated with autoimmune destruction and fibrosis of the AV node, most commonly resulting in a congenital complete heart block (CCHB). We report the case of a 23-year-old mother who was found to have a fetus with significant bradycardia at a 21-week anatomy ultrasound. Subsequent fetal echocardiograms demonstrated a third-degree heart block, and laboratory workup of the mother was positive for SSA antibodies. Successful care of the fetus required multidisciplinary coordination to ensure adequate antepartum care, successful delivery of the fetus, and proper cardiovascular management of the neonate after birth. We discuss etiologies of fetal bradycardia, proper imaging techniques to diagnose fetal cardiac abnormalities, and the management of a neonate with CCHB after birth. Lastly, we emphasize how adequate operating room preparation and multidisciplinary planning are essential for optimal outcomes during time-sensitive and high-risk operating room procedures.
{"title":"Congenital Complete Heart Block Requiring Temporary Pacemaker Placement at Birth: A Case Report.","authors":"Karthi Murari, Clint Humpherys, Nathaniel Lata, Christian Taylor, Sanket Shah, Todd Glenski","doi":"10.1177/10892532251349364","DOIUrl":"10.1177/10892532251349364","url":null,"abstract":"<p><p>Congenital heart block (CHB) is a rare congenital cardiac disease where disruption of the atrioventricular (AV) node results in cardiac conduction abnormalities. The majority of CHB cases are associated with neonatal lupus antibodies that are associated with autoimmune destruction and fibrosis of the AV node, most commonly resulting in a congenital complete heart block (CCHB). We report the case of a 23-year-old mother who was found to have a fetus with significant bradycardia at a 21-week anatomy ultrasound. Subsequent fetal echocardiograms demonstrated a third-degree heart block, and laboratory workup of the mother was positive for SSA antibodies. Successful care of the fetus required multidisciplinary coordination to ensure adequate antepartum care, successful delivery of the fetus, and proper cardiovascular management of the neonate after birth. We discuss etiologies of fetal bradycardia, proper imaging techniques to diagnose fetal cardiac abnormalities, and the management of a neonate with CCHB after birth. Lastly, we emphasize how adequate operating room preparation and multidisciplinary planning are essential for optimal outcomes during time-sensitive and high-risk operating room procedures.</p>","PeriodicalId":46500,"journal":{"name":"Seminars in Cardiothoracic and Vascular Anesthesia","volume":" ","pages":"219-224"},"PeriodicalIF":1.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144259025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-01Epub Date: 2025-04-12DOI: 10.1177/10892532251333682
Matthew M Goodmanson, Destiny F Chau, Leah M Landsem, Gregory J Latham
This review focuses on highlighting published literature in 2024 relating to the anesthetic management of children with congenital heart disease (CHD). Four major themes are discussed: (i) enhanced recovery after pediatric cardiac surgery (ERAS); (ii) acute kidney injury following cardiac surgery; (iii) neurodevelopmental outcomes and neuromonitoring; and (iv) cardiopulmonary bypass (CPB) and blood conservation strategies.
{"title":"The Year in Review: Anesthesia for Congenital Heart Disease 2024.","authors":"Matthew M Goodmanson, Destiny F Chau, Leah M Landsem, Gregory J Latham","doi":"10.1177/10892532251333682","DOIUrl":"10.1177/10892532251333682","url":null,"abstract":"<p><p>This review focuses on highlighting published literature in 2024 relating to the anesthetic management of children with congenital heart disease (CHD). Four major themes are discussed: (i) enhanced recovery after pediatric cardiac surgery (ERAS); (ii) acute kidney injury following cardiac surgery; (iii) neurodevelopmental outcomes and neuromonitoring; and (iv) cardiopulmonary bypass (CPB) and blood conservation strategies.</p>","PeriodicalId":46500,"journal":{"name":"Seminars in Cardiothoracic and Vascular Anesthesia","volume":" ","pages":"103-115"},"PeriodicalIF":1.1,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143988956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-01Epub Date: 2025-03-17DOI: 10.1177/10892532251328204
Akira Katayama, Palak Patel, Abigail Pianelli, Ryan Wang, Tetsuro Sakai
This review highlights noteworthy literature published in 2024 pertinent to anesthesiologists and critical care physicians caring for patients undergoing abdominal organ transplantation. We feature 13 studies from over 5555 peer-reviewed publications on kidney transplantation, 4 studies from 1963 publications on pancreas transplantation, and 3 studies from 1879 publications on intestinal transplantation. The liver transplantation section includes a special focus on 22 studies from 4571 clinical trials published in 2024. We identified the new findings with our specialty interest, including cardiovascular risk assessment, machine perfusion, hemodynamic management, mode of anesthesia and regional techniques, donor management, fluid management, intraoperative monitoring, blood salvage, frailty, and rehabilitation and prehabilitation.
{"title":"Abdominal Organ Transplantation: Noteworthy Literature in 2024.","authors":"Akira Katayama, Palak Patel, Abigail Pianelli, Ryan Wang, Tetsuro Sakai","doi":"10.1177/10892532251328204","DOIUrl":"10.1177/10892532251328204","url":null,"abstract":"<p><p>This review highlights noteworthy literature published in 2024 pertinent to anesthesiologists and critical care physicians caring for patients undergoing abdominal organ transplantation. We feature 13 studies from over 5555 peer-reviewed publications on kidney transplantation, 4 studies from 1963 publications on pancreas transplantation, and 3 studies from 1879 publications on intestinal transplantation. The liver transplantation section includes a special focus on 22 studies from 4571 clinical trials published in 2024. We identified the new findings with our specialty interest, including cardiovascular risk assessment, machine perfusion, hemodynamic management, mode of anesthesia and regional techniques, donor management, fluid management, intraoperative monitoring, blood salvage, frailty, and rehabilitation and prehabilitation.</p>","PeriodicalId":46500,"journal":{"name":"Seminars in Cardiothoracic and Vascular Anesthesia","volume":" ","pages":"147-158"},"PeriodicalIF":1.1,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143651338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}